Sterling Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
Sterling Capital Management's IRWD Position: Q3 2026 in Review
Sterling Capital Management increased its Ironwood Pharmaceuticals (IRWD) stake by 571% in Q3 2026, buying an estimated $18.6K and bringing the position to 5,248 shares worth $20.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2173.
Sterling Capital Management first reported a position in IRWD in Q3 2024 and has held it in 9 quarters since. 232 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.
- Sterling Capital Management held 5,248 shares of Ironwood Pharmaceuticals worth $20.8K as of Q3 2026.
- Sterling Capital Management bought 4,466 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $18.6K.
- Ironwood Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2173 holding.
- Sterling Capital Management first reported a position in Ironwood Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
- 232 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.
Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.